Business
Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
Distinguished Investor Group Includes Kraken, American Ventures, Exodus (NYSE: EXOD), XtalPi (2228.hk), DL Holdings (1709.hk) GPTX by Jihan Wu and Leading
About this update from Prenetics Global Limited
[{"type":"text","content":"Distinguished Investor Group Includes Kraken, American Ventures, Exodus (NYSE: EXOD), XtalPi (2228.hk), DL Holdings (1709.hk) GPTX by Jihan Wu and Leading Institutions World No. 1 and 4-time Grand Slam champion Aryna Sabalenka expands her stake in Prenetics Adrian Cheng, one of Asia’s most influential visionaries and an original cornerstone investor in Prenetics’ IPO increases his stake, reflecting enduring conviction in the company’s global vision IM8 Achieves $100 Million in Annual Recurring Revenue Within 11 Months of Launch IM8 Guidance $180 to $200 Million Revenue in 2026, Driving Company Toward Multi-Billion Dollar Valuation Prenetics CEO Danny Yeung to Host Investor Conference Call, Today at 11:00am ET CHARLOTTE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced the successful pricing of a public offering of 2,992,596 Class A ordinary shares and/or pre-funded warrants to purchase Class A ordinary shares, together with accompanying Class A warrants and Class B warrants to purchase up to an aggregate of 5,985,192 Class A ordinary shares at a combined price per Class A ordinary share and/or pre-funded warrant and accompanying Class A warrant and Class B warrant of $16.08. The gross proceeds to the Company from the offering are expected to be approximately $48 million, before deducting placement agent fees and offering expenses. The offering was led by sole placement agent Dominari Securities LLC. The offering includes a double warrant structure, with the Class A warrant exercisable at $24.12 per Class A ordinary share (50% premium to the $16.08 offering price) and with the Class B warrant exercisable at $32.16 per Class A ordinary share (100% premium to the $16.08 offering price). Both warrants will be exercisable immediately upon issuance and expire five years after issuance. The Company may receive up to total proceeds of approximately $216 million ($168 million in additional gross proceeds), if all of the Class A warrants and Class B warrants are exercised for cash in full. This strategic capital raise was supported by a distinguished group of institutional and individual investors. Notable participants include: Kraken - One of the world's largest cryptocurrency exchanges and digital asset platforms. Strategic V...